Kim Vanstraelen
Leuven, VLG, Belgium
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications
The tolerability of sofosbuvir/velpatasvir for 12 weeks in patients treated in the ASTRAL 1, 2 and 3 studies: A pooled safety analysis.
Journal: Journal of viral hepatitis
Published: October 10, 2022
Global Real-World Evidence of Sofosbuvir/Velpatasvir as a Highly Effective Treatment and Elimination Tool in People with Hepatitis C Infection Experiencing Mental Health Disorders.
Journal: Viruses
Published: September 27, 2022
Guidelines Have a Key Role in Driving HCV Elimination by Advocating for Simple HCV Care Pathways.
Journal: Advances in therapy
Published: December 16, 2020
Global real-world evidence of sofosbuvir/velpatasvir as simple, effective HCV treatment: Analysis of 5552 patients from 12 cohorts.
Journal: Liver international : official journal of the International Association for the Study of the Liver
Published: February 21, 2020
Posaconazole plasma exposure correlated to intestinal mucositis in allogeneic stem cell transplant patients.
Journal: European journal of clinical pharmacology
Published: December 10, 2015
Chemotherapy-Induced Intestinal Mucosal Barrier Damage: a Cause of Falsely Elevated Serum 1,3-Beta-d-Glucan Levels?
Journal: Journal of clinical microbiology
Published: November 07, 2015
Pharmacokinetics of Posaconazole Oral Suspension in Children Dosed According to Body Surface Area.
Journal: The Pediatric infectious disease journal
Published: November 07, 2015
Factors impacting unbound vancomycin concentrations in different patient populations.
Journal: Antimicrobial agents and chemotherapy
Published: May 20, 2015
Investigation of Saliva as an Alternative to Plasma Monitoring of Voriconazole.
Journal: Clinical pharmacokinetics
Published: April 26, 2015
Key Elements in Determining Voriconazole Protein Binding Characteristics: Comment on "Determination of Plasma Unbound Fraction of Voriconazole in Patients Treated With a Prophylactic or a Curative Treatment".
Journal: Therapeutic drug monitoring
Published: December 20, 2014
Impact of hypoalbuminemia on voriconazole pharmacokinetics in critically ill adult patients.
Journal: Antimicrobial agents and chemotherapy
Published: September 04, 2014
Protein-binding characteristics of voriconazole determined by high-throughput equilibrium dialysis.
Journal: Journal of pharmaceutical sciences
Published: April 03, 2014
Last Updated: 09/26/2026